LifeMD Statistics
Share Statistics
LifeMD has 45.45M
shares outstanding. The number of shares has increased by 7.27%
in one year.
| Shares Outstanding | 45.45M |
| Shares Change (YoY) | 7.27% |
| Shares Change (QoQ) | 2.94% |
| Owned by Institutions (%) | 38.24% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 117 |
| FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 5.34M, so 11.75% of the outstanding
shares have been sold short.
| Short Interest | 5.34M |
| Short % of Shares Out | 11.75% |
| Short % of Float | 14.24% |
| Short Ratio (days to cover) | 1.8 |
Valuation Ratios
The PE ratio is -10.8 and the forward
PE ratio is 38.09.
LifeMD's PEG ratio is
0.44.
| PE Ratio | -10.8 |
| Forward PE | 38.09 |
| PS Ratio | 0.96 |
| Forward PS | 1.2 |
| PB Ratio | 0 |
| P/FCF Ratio | 34.12 |
| PEG Ratio | 0.44 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for LifeMD.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.81,
with a Debt / Equity ratio of 0.
| Current Ratio | 0.81 |
| Quick Ratio | 0.76 |
| Debt / Equity | 0 |
| Debt / EBITDA | -3.77 |
| Debt / FCF | 4.2 |
| Interest Coverage | -7.4 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $698,861.31 |
| Profits Per Employee | $-62,110.96 |
| Employee Count | 304 |
| Asset Turnover | 2.93 |
| Inventory Turnover | -10.71 |
Taxes
| Income Tax | 402K |
| Effective Tax Rate | -2.19% |
Stock Price Statistics
The stock price has increased by 38.13% in the
last 52 weeks. The beta is 2.23, so LifeMD's
price volatility has been higher than the market average.
| Beta | 2.23 |
| 52-Week Price Change | 38.13% |
| 50-Day Moving Average | 6.64 |
| 200-Day Moving Average | 5.68 |
| Relative Strength Index (RSI) | 80.65 |
| Average Volume (20 Days) | 1,771,890 |
Income Statement
In the last 12 months, LifeMD had revenue of 212.45M
and earned -18.88M
in profits. Earnings per share was -0.53.
| Revenue | 212.45M |
| Gross Profit | 242.4M |
| Operating Income | -16.14M |
| Net Income | -18.88M |
| EBITDA | -6.65M |
| EBIT | -16.14M |
| Earnings Per Share (EPS) | -0.53 |
Full Income StatementBalance Sheet
The company has 35M in cash and 25.1M in
debt, giving a net cash position of 9.9M.
| Cash & Cash Equivalents | 35M |
| Total Debt | 25.1M |
| Net Cash | 9.9M |
| Retained Earnings | -236,253.2B |
| Total Assets | 73.61M |
| Working Capital | -10.93M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was 17.51M
and capital expenditures -11.54M, giving a free cash flow of 5.98M.
| Operating Cash Flow | 17.51M |
| Capital Expenditures | -11.54M |
| Free Cash Flow | 5.98M |
| FCF Per Share | 0.15 |
Full Cash Flow StatementMargins
Gross margin is 114.1%, with operating and profit margins of -7.6% and -8.89%.
| Gross Margin | 114.1% |
| Operating Margin | -7.6% |
| Pretax Margin | -8.63% |
| Profit Margin | -8.89% |
| EBITDA Margin | -3.13% |
| EBIT Margin | -7.6% |
| FCF Margin | 2.81% |
